Clinical Trials Logo

Healthy Male Subjects clinical trials

View clinical trials related to Healthy Male Subjects.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05478109 Not yet recruiting - Clinical trials for Healthy Male Subjects

A Clinical Trial of XZP-3287 for Material Balance

Start date: August 2, 2022
Phase: Phase 1
Study type: Interventional

A single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of [14C] XZP-3287

NCT ID: NCT02614352 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Start date: n/a
Phase: Phase 1
Study type: Interventional

Primary object : Evaluate pharmacokinetic property AG1502 and Candesartan 32mg and Atorvastatin 40mg in healthy male subjects.

NCT ID: NCT01928563 Not yet recruiting - Clinical trials for Healthy Male Subjects

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine

Start date: September 2013
Phase: Phase 1
Study type: Interventional

This study is designed to investigate the pharmacokinetic drug interaction between Udenafil and Dapoxetine in healthy male subjects Design : Randomized, open-label, 3-treatment, 6-sequence, 3-period crossover study Investigational Product : Udenafil, Dapoxetine

NCT ID: NCT01882296 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

AGSPT_PD
Start date: n/a
Phase: Phase 1
Study type: Interventional

Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects Secondary object : Evaluate Dose-response of S-pantoprazole and pantoprazole and compare each dose-response

NCT ID: NCT01821521 Not yet recruiting - Clinical trials for Healthy Male Subjects

Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects

S-Pantoprazole
Start date: June 2013
Phase: Phase 1
Study type: Interventional

Primary object : Evaluate pharmacokinetic property administered S-pantoprazole 20mg and Pantoprazole 40mg in healthy male subjects Secondary object : Evaluate safety administered S-pantoprazole 20mg and Pantoprazole 40mg in healthy male subjects